Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg lowers target price on Glencore

(Sharecast News) - Analysts at Berenberg lowered their target price on mining giant Glencore from 400.0p to 380.0p on Thursday after the firm's 2025 started "on a soft note". Berenberg updated its model on Glencore following the company's Q125 operating update on 30 April, which was seen as a miss by both the analysts and the wider market.

"Operationally, a mixture of weaker grades, mine sequencing and some weather impacts at key assets resulted in production volumes coming in lighter than our expectations, particularly in copper and zinc," said Berenberg.

The German bank, which has a 'buy' rating on the stock, noted that guidance across the group was maintained, with the exception of a cut in thermal coal guidance to 87-95m tonnes from 92-100m tonnes.

Berenberg said "perhaps more disappointing" was the fact that Glencore's marketing business was tracking to the mid-point of its $2.2bn-3.2bn underlying earnings guidance range. Berenebrg said this would appear to mean that marketing was "not performing as well as the market was hoping" amid such global volatility.

"We update our model for the quarter, and move to the lower ends of the guidance range for copper and zinc. This reduces EPS by 6%. We then make negative adjustments to our marketing margins to bring EBIT in line with guidance; this takes our total EPS reduction for 2025 to -19%," said Glencore.

"The share price reaction likely reflects the market's concern about further risks to volume guidance and weaker marketing performance. The shares are trading on 0.65x NAV and 2.7x 2025E EBITDA; in our view, Glencore needs a decent Q2 (we have been given implied Q2 volumes via the H1/H2 volume split), coupled with stronger thermal coal prices and/or some self-help levers being pulled to drive a re-rating."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.